MicroRNA-139 suppresses proliferation in luminal type breast cancer cells by targeting Topoisomerase II alpha
- 1 August 2015
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 463 (4) , 1077-1083
Abstract
No abstract availableKeywords
Funding Information
- National National Science Foundation of China (81202138)
- Natural Science Basic Research Plan in Shaanxi Province (2011JQ4019)
- Wu Jieping Medical Fund (320.6750.13293)
- Discipline Boosting Project of Xijing Hospital (XJZT12M03, XJZT13M07)
This publication has 26 references indexed in Scilit:
- MicroRNA signatures highlight new breast cancer subtypesGene, 2015
- Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008Journal of Clinical Oncology, 2015
- Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group StatementAnnals of Oncology, 2012
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Research and Treatment, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized TrialsJNCI: Journal of the National Cancer Institute, 2008
- A microRNA expression signature of human solid tumors defines cancer gene targetsProceedings of the National Academy of Sciences, 2006
- Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast CancerThe American Journal of Pathology, 2000
- Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: Correlation with clinico-pathological featuresVirchows Archiv, 1993
- Biochemical basis for the interactions of type I and type II topoisomerases with DNAPharmacology & Therapeutics, 1989